Rezultati pretraživanja
  1. prije 12 sati

    Good question ! Our final data analysis may reveal some hints to the answer🤞🧬🔬

  2. 4. velj

    Meet the newly elected leaders of the IMI States Representatives Group! Chair: Marta Gómez Quintanilla 🇪🇸 Vice-Chair: Jan Skriwanek 🇩🇪 Thanks to outgoing chair Gunnar Sandberg 🇸🇪 for his work for the group Meet the SRG

    Jan Skriwanek and Marta Gómez Quintanilla
  3. 4. velj

    Lack of quality data on blood cancers is a problem. Big data project is pooling data from across EU to better understand the different cancer subtypes, ultimately leading to better treatments.

  4. 4. velj

    Hoy iniciamos un mes dedicado a explicar cómo contribuye a dar respuesta a algunos de los retos a los que se enfrentan los investigadores en cáncer

  5. 4. velj

    It's . How are we contributing to the ? The last 3 IMI calls for proposals have pitched another €26 million to the €130 million already dedicated to cancer research projects. today launches public outreach

  6. 3. velj

    La herramienta online LimTox, desarrollada en el en el marco del proyecto eTOX , ya está disponible para todos los usuarios y es gratuita.

  7. "Nothing about us, without us" Learn how patients are bringing new perspectives to pharmaceutical R&D 🔬

  8. 1. velj

    The conclusions from yesterday's event by MEP Petra De Sutter was that the future of European Health Research is in PARTNERSHIPS between sectors, disciplines, countries , .

  9. 31. sij

    Our eTOX project developed LimTox, a text mining tool that extracts associations between compounds and toxicological end points More IMI project outputs

  10. 31. sij

    Our last IMI2 - Call 20 webinar was today - all presentations, recordings and participant lists are on our website at More on IMI2 - Call 20:

  11. Submit your proposal📝until 21 April 2020! The total budget of the 20th call of Innovative Medicines Initiative 2 () is 270 million euros.💸👉🏾

  12. 31. sij

    In February, we will focus on cancer, kicking off on 4 February on the occasion of and the launch of the Commission's event supported by . Image:

    Prikaži ovu nit
  13. 31. sij

    And we looked at the work of who are asking when (and how) the health research and development community should involve patients in their work.

    Prikaži ovu nit
  14. 31. sij

    We celebrated the growth of , whose new incarnation as EFO-EUPATI will extend the lifetime of the academy into the future. We spoke to one of the course coordinators about the short history of patient advocacy

    Prikaži ovu nit
  15. 31. sij

    We wrote about how researchers from tested different ways to engage patients, including reaching out to suspected early ’s sufferers by flagging internet searches like “forgetfulness”

    Prikaži ovu nit
  16. 31. sij

    Our Director Pierre Meulien noted how relatively recently the practice has gained steam "Drug-makers have only recently started to give drug-takers a say in how their medicines are made, turning patients into a new generation of experts"

    Prikaži ovu nit
  17. 31. sij
  18. 30. sij

    This editorial, in which IMI is given special mention, calls for the EU and UK to stay close after Brexit. It rightfully notes that research has always been central to European unity

  19. 30. sij

    The last IMI2 - Call 20 webinar is tomorrow (31/01) and we're talking protein drug products! Register / catch up on previous webinars: Learn more about IMI2 - Call 20:

  20. 30. sij

    When and how should the research and development community involve in their work? IMI’s project is trying to find out!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.